Q Bio Secures $27M for Preventative Full-Body Scans

Q Bio wants to read your health forecast.

What’s happening: The AI-enhanced full-body MRI startup raised $27M in funding from a16z, Founders Fund, Khosla Ventures, and others.

Piloting next-gen medical imaging tech in its Silicon Valley clinic, Q Bio is accelerating manufacturing, seeking regulatory approvals, and enlisting healthcare partners.

Copy that. Q Bio’s platform features a proprietary MRI application called tensor field mapping, with its Mark I machine touted as faster, cheaper, and 100x more powerful.

Gaining 3K anatomical measurements through a 10-minute scan, AI generates a patient’s digital twin, assessing for current concerns plus disease prediction.

Inside Out

From cancer to heart health, comprehensive scans are scaling up.

• Early cancer detection company Ezra landed $21M this year and partnered with RAYUS Technology to open clinics across the US.
• Raising $70M in ’22, full-body scan startup Prenuvo is planning to open 11 sites this year.
• Envisioning holistic health on the go, Forward added $100M for self-serve care pods.

In Europe, Spotify CEO Daniel Ek’s Neko Health, a clinic also translating scans into digital twins, expanded to London this summer.

False positive. While experts question the morality of elective MRIs, consumers see the scans as a path to prevention.

Takeaway: Posed with the decision to know less or more, consumers have an easy choice. But, integrating scans as the new standard of care won’t come without resistance from the status quo.